Annual Non Current Assets
$376.47 M
-$145.36 M-27.86%
December 31, 2022
Summary
- As of March 9, 2025, SRNE annual long term assets is $376.47 million, with the most recent change of -$145.36 million (-27.86%) on December 31, 2022.
- During the last 3 years, SRNE annual non current assets has fallen by -$113.58 million (-23.18%).
- SRNE annual non current assets is now -27.86% below its all-time high of $521.83 million, reached on December 31, 2021.
Performance
SRNE Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$323.58 M
-$35.72 M-9.94%
June 30, 2023
Summary
- As of March 9, 2025, SRNE quarterly long term assets is $323.58 million, with the most recent change of -$35.72 million (-9.94%) on June 30, 2023.
- Over the past year, SRNE quarterly non current assets has dropped by -$35.72 million (-9.94%).
- SRNE quarterly non current assets is now -48.12% below its all-time high of $623.66 million, reached on June 30, 2021.
Performance
SRNE Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
SRNE Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.9% | -9.9% |
| 3 y3 years | -23.2% | -9.9% |
| 5 y5 years | -6.3% | -9.9% |
SRNE Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.9% | at low | -38.3% | at low |
| 5 y | 5-year | -27.9% | at low | -48.1% | at low |
| alltime | all time | -27.9% | -100.0% | -48.1% | -100.0% |
Sorrento Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $323.58 M(-9.9%) |
| Mar 2023 | - | $359.30 M(-4.6%) |
| Dec 2022 | $96.37 M(-44.3%) | $376.47 M(-14.2%) |
| Sep 2022 | - | $438.66 M(+0.6%) |
| Jun 2022 | - | $436.08 M(-16.9%) |
| Mar 2022 | - | $524.52 M(+0.5%) |
| Dec 2021 | $172.99 M(+100.6%) | $521.83 M(-5.5%) |
| Sep 2021 | - | $552.07 M(-11.5%) |
| Jun 2021 | - | $623.66 M(+79.3%) |
| Mar 2021 | - | $347.91 M(-22.6%) |
| Dec 2020 | $86.23 M(+27.6%) | $449.59 M(-9.4%) |
| Sep 2020 | - | $496.10 M(+3.8%) |
| Jun 2020 | - | $478.07 M(-1.8%) |
| Mar 2020 | - | $486.92 M(-0.6%) |
| Dec 2019 | $67.59 M(-62.4%) | $490.04 M(-0.7%) |
| Sep 2019 | - | $493.31 M(-0.0%) |
| Jun 2019 | - | $493.54 M(+0.5%) |
| Mar 2019 | - | $490.89 M(+10.4%) |
| Dec 2018 | $179.56 M(+504.6%) | $444.52 M(+0.4%) |
| Sep 2018 | - | $442.72 M(+11.3%) |
| Jun 2018 | - | $397.77 M(-0.6%) |
| Mar 2018 | - | $400.31 M(-0.4%) |
| Dec 2017 | $29.70 M(-66.9%) | $401.91 M(-8.7%) |
| Sep 2017 | - | $440.08 M(+35.8%) |
| Jun 2017 | - | $324.17 M(+6.9%) |
| Mar 2017 | - | $303.13 M(-2.8%) |
| Dec 2016 | $89.65 M(-36.4%) | $311.93 M(+50.5%) |
| Sep 2016 | - | $207.22 M(+1.0%) |
| Jun 2016 | - | $205.14 M(+1.5%) |
| Mar 2016 | - | $202.05 M(-0.2%) |
| Dec 2015 | $141.02 M(+90.8%) | $202.50 M(+1.0%) |
| Sep 2015 | - | $200.49 M(+153.8%) |
| Jun 2015 | - | $79.01 M(+14.4%) |
| Mar 2015 | - | $69.09 M(+2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $73.92 M(+126.5%) | $67.63 M(+16.0%) |
| Sep 2014 | - | $58.29 M(-1.0%) |
| Jun 2014 | - | $58.88 M(-0.8%) |
| Mar 2014 | - | $59.38 M(-0.9%) |
| Dec 2013 | $32.63 M(+521.3%) | $59.95 M(+92.7%) |
| Sep 2013 | - | $31.11 M(+1566.8%) |
| Jun 2013 | - | $1.87 M(+7.5%) |
| Mar 2013 | - | $1.74 M(+13.5%) |
| Dec 2012 | $5.25 M(+47.6%) | $1.53 M(+18.3%) |
| Sep 2012 | - | $1.29 M(+8.7%) |
| Jun 2012 | - | $1.19 M(+0.4%) |
| Mar 2012 | - | $1.19 M(+17.3%) |
| Dec 2011 | $3.56 M(-35.9%) | $1.01 M(+4.7%) |
| Sep 2011 | - | $966.20 K(+8.8%) |
| Jun 2011 | - | $887.80 K(+3.8%) |
| Mar 2011 | - | $855.50 K(+537.0%) |
| Dec 2010 | $5.55 M(+60.6%) | $134.30 K(+7.4%) |
| Sep 2010 | - | $125.10 K(-4.9%) |
| Jun 2010 | - | $131.60 K(+0.1%) |
| Mar 2010 | - | $131.50 K(+37.0%) |
| Dec 2009 | $3.46 M(>+9900.0%) | $96.00 K(+67.5%) |
| Sep 2009 | - | $57.30 K(>+9900.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Dec 2007 | $21.90 K(>+9900.0%) | $0.00(0.0%) |
| Sep 2007 | - | $0.00(0.0%) |
| Jun 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00 |
| Dec 2006 | $0.00(0.0%) | - |
| Dec 2005 | $0.00(0.0%) | - |
| Dec 2004 | $0.00(0.0%) | - |
| Dec 2003 | $0.00 | - |
FAQ
- What is Sorrento Therapeutics annual long term assets?
- What is the all time high annual non current assets for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual non current assets year-on-year change?
- What is Sorrento Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly non current assets year-on-year change?
What is Sorrento Therapeutics annual long term assets?
The current annual non current assets of SRNE is $376.47 M
What is the all time high annual non current assets for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual long term assets is $521.83 M
What is Sorrento Therapeutics annual non current assets year-on-year change?
Over the past year, SRNE annual long term assets has changed by -$145.36 M (-27.86%)
What is Sorrento Therapeutics quarterly long term assets?
The current quarterly non current assets of SRNE is $323.58 M
What is the all time high quarterly non current assets for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly long term assets is $623.66 M
What is Sorrento Therapeutics quarterly non current assets year-on-year change?
Over the past year, SRNE quarterly long term assets has changed by -$35.72 M (-9.94%)